LightIntegra’s first product, ThromboLUX, was introduced to the US market in late 2017 and is starting to make a splash – by using ThromboLUX to determine platelet activation status, hospitals are seeing unprecedented reductions in platelet use for blood cancer treatment. Learn more about how ThromboLUX helps hospitals allocate platelets for more effective use,  and hear about its other applications in transfusion medicine and diagnostics.   

Date: Wednesday, March 28, 2018

Time:

5:30-6:00pm: arrival & refreshments

6:00-7:00pm: presentation and questions/discussion

7:00-7:30pm: refreshments & networking

Location: Change Healthcare – 10711 Cambie Road, Richmond

Cost: Free for LSBC members and $25 for Non-members

Click here to order tickets

For more information please contact:

Ryan Butt, Manager Events & Outreach

Phone: 604 669-9909 ext. 104 & Email: rbutt@lifesciencesbc.ca